California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014

As lawmakers begin to prioritize funding measures for FY14, it is essential that we safeguard the budget of the U.S. Food and Drug Administration.

http://www.prweb.com/releases/2013/5/prweb10769522.htm